These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 35041907

  • 21. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor.
    Ohmura Y, Kumamoto H, Tsutsui-Kimura I, Minami M, Izumi T, Yoshida T, Yoshioka M.
    J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of the 5-HT(1A) Receptor Agonist Tandospirone on ACTH-Induced Sleep Disturbance in Rats.
    Tsutsui R, Shinomiya K, Sendo T, Kitamura Y, Kamei C.
    Biol Pharm Bull; 2015; 38(6):884-8. PubMed ID: 26027828
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.
    Horiguchi M, Meltzer HY.
    Psychopharmacology (Berl); 2012 May; 221(2):205-15. PubMed ID: 22227609
    [Abstract] [Full Text] [Related]

  • 27. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
    Mulroney SE, Skudlarek C, Shemer A, Lumpkin MD, Kellar KJ.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease: an open-label study.
    Takei A, Fukazawa T, Hamada T, Sohma H, Yabe I, Sasaki H, Tashiro K.
    Clin Neuropharmacol; 2004 Feb; 27(1):9-13. PubMed ID: 15090930
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression.
    Inan S, Chen X, Eisenstein EM, Meissler JJ, Geller EB, Tallarida C, Watson M, Doura M, Barrett JE, Cowan A, Rawls SM, Adler MW, Eisenstein TK.
    Life Sci; 2021 Nov 15; 285():120014. PubMed ID: 34619167
    [Abstract] [Full Text] [Related]

  • 33. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A.
    Palliat Med; 2006 Nov 15; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats.
    Dahan A, Yassen A, Bijl H, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.
    Br J Anaesth; 2005 Jun 15; 94(6):825-34. PubMed ID: 15833777
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intermittent hypercapnic hypoxia induces respiratory hypersensitivity to fentanyl accompanied by tonic respiratory depression by endogenous opioids.
    Brackley AD, Andrade MA, Toney GM.
    J Physiol; 2020 Aug 15; 598(15):3239-3257. PubMed ID: 32415789
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. KEA-1010, a ketamine ester analogue, retains analgesic and sedative potency but is devoid of Psychomimetic effects.
    Harvey M, Sleigh J, Voss L, Bickerdike M, Dimitrov I, Denny W.
    BMC Pharmacol Toxicol; 2019 Dec 19; 20(1):85. PubMed ID: 31856925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.